Ads
related to: actemra cost per year- Check Patient Eligibility
See If Your Patients Are Eligible
For ACTEMRA® Co-Pay Assistance
- Contact A Representative
Contact A Representative To
Get More Info About ACTEMRA®.
- Patient Support Services
Visit The Site To Learn About
Patient Access Services.
- Efficacy & Safety
Learn About The Efficacy & Safety
Before Prescribing To Your Patients
- Coverage Map For HCPs
Fill Out Form To Request
A Local Coverage Map
- Resource Library
View Additional HCP Resources
To Learn About Treatment.
- Check Patient Eligibility
Search results
Results From The WOW.Com Content Network
Tocilizumab, sold under the brand name Actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, giant cell arteritis, cytokine release syndrome, COVID‑19, and systemic sclerosis-associated interstitial lung disease (SSc-ILD).
A 2014 Canadian study calculated the cost per life-year-gained with treatment as CAN$4.62 million (US$4,571,564) and cost per quality-adjusted-life-year as CAN$2.13 million (US$2,112,398)."The incremental cost per life year and per QALY gained is CAN$4.62 million and CAN$2.13 million, respectively.
Medication costs can be the selling price from the manufacturer, that price together with shipping, the wholesale price, the retail price, and the dispensed price. [3]The dispensed price or prescription cost is defined as a cost which the patient has to pay to get medicines or treatments which are written as directions on prescription by a prescribers. [4]
Roche reported that it earned more than 2.7 billion Swiss francs - more than $3 billion based on current exchange rates - from worldwide sales of its biologic Actemra last year. Actemra sales were ...
Last year consumers' out-of-pocket costs were capped at about $3,300 per year. As of Jan. 1, the cap dropped to $2,000 per year. As of Jan. 1, the cap dropped to $2,000 per year.
The 15 drugs accounted for $41 billion, or 14%, of total Medicare Part D spending between Nov. 1, 2023, and Oct. 1, 2024.
Ads
related to: actemra cost per year